Jacobs Levy Equity Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-160,244
| Closed | -$120K | – | 1108 |
|
|
2018
Q4 | $120K | Buy |
160,244
+75,514
| +89% | +$56.5K | ﹤0.01% | 932 |
|
|
2018
Q3 | $180K | Buy |
84,730
+208
| +0.2% | +$442 | ﹤0.01% | 938 |
|
|
2018
Q2 | $195K | Buy |
84,522
+16,322
| +24% | +$37.7K | ﹤0.01% | 959 |
|
|
2018
Q1 | $217K | Buy |
68,200
+19,800
| +41% | +$63K | ﹤0.01% | 913 |
|
|
2017
Q4 | $198K | Buy |
48,400
+6,600
| +16% | +$27K | ﹤0.01% | 908 |
|
|
2017
Q3 | $189K | Buy |
+41,800
| New | +$189K | ﹤0.01% | 875 |
|
|
2017
Q2 | – | Sell |
-21,000
| Closed | -$193K | – | 1096 |
|
|
2017
Q1 | $193K | Buy |
+21,000
| New | +$193K | ﹤0.01% | 805 |
|
|
2016
Q3 | – | Sell |
-15,290
| Closed | -$188K | – | 1252 |
|
|
2016
Q2 | $188K | Buy |
+15,290
| New | +$188K | ﹤0.01% | 1017 |
|